Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Neuroprotection by Magnesium Sulfate Given to Women at Risk of Very Preterm Birth
This study has been completed.
Study NCT00120588 Information provided by University Hospital, Rouen
First Received on July 11, 2005. Last Updated on February 14, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Preterm Birth
Periventricular Leukomalacia
Brain Ischemia
Intracranial Hemorrhages
Additional conditions recognized in this trial
Hemorrhage
Ischemia
Leukomalacia, Periventricular
Premature Birth
More general conditions related to this trial
Brain Diseases
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Encephalomalacia
Infant, Newborn, Diseases
Infant, Premature, Diseases
Nervous System Diseases
Obstetric Labor Complications
Obstetric Labor, Premature
Pathologic Processes
Pregnancy Complications
Vascular Diseases
Interventions listed in this trial
magnesium
Additional drug interventions recognized in this trial
Magnesium Sulfate
More general drug interventions related to this trial
Analgesics
Anesthetics
Anti-Arrhythmia Agents
Anticonvulsants
Calcium Channel Blockers
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Depressants
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Sensory System Agents
Therapeutic Uses
Tocolytic Agents
Sponsors listed in this trial
University Hospital, Rouen
Ministry of Health, France
Back to top of Main Content
